UniProt Q8ULI9
Protease NL4-3 (Q8ULI9)
Protease NL4-3 (UniProt Q8ULI9): 108 experimental structures on GenesisL1, 54 ligands bound, 114 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q8ULI9
- Protein
- Protease NL4-3
- Experimental structures
- 108
- Predicted models
- 0
- Ligands
- 54
- Pockets
- 114 · 108 records with a druggable one
Structures
108 records of Q8ULI9 in the MolNFT archive: 108 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6DGX | Crystal structure of HIV-1 Protease NL4-3 WT in complex with darunavir | x-ray diffraction | B, A | 017, SO4 | 1 (best 0.71) |
| 6DGX | Crystal structure of HIV-1 protease NL4-3 wt in complex with darunavir | x-ray diffraction | B, A | 017, SO4 | 1 (best 0.71) |
| 6DGY | Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass1 | x-ray diffraction | B, A | SO4, K13 | 1 (best 0.72) |
| 6DGY | Crystal structure of HIV-1 protease NL4-3 wt in complex with UMASS1 | x-ray diffraction | B, A | SO4, K13 | 1 (best 0.72) |
| 6DGZ | Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass6 | x-ray diffraction | B, A | SO4, A60 | 1 (best 0.73) |
| 6DGZ | Crystal structure of HIV-1 protease NL4-3 wt in complex with UMASS6 | x-ray diffraction | B, A | SO4, A60 | 1 (best 0.73) |
| 6OPS | HIV-1 Protease NL4-3 WT in complex with darunavir | x-ray diffraction | B, A | 017 | 1 (best 0.71) |
| 6OPS | HIV-1 protease NL4-3 wt in complex with darunavir | x-ray diffraction | B, A | 017 | 1 (best 0.71) |
| 6OXO | HIV-1 Protease NL4-3 WT in Complex with LR2-91 | x-ray diffraction | B, A | SO4, NJM | 1 (best 0.71) |
| 6OXO | HIV-1 protease NL4-3 wt in complex with LR2-91 | x-ray diffraction | B, A | SO4, NJM | 1 (best 0.71) |
| 6OXP | HIV-1 Protease NL4-3 WT in Complex with UMass3 | x-ray diffraction | B, A | SO4, K2A | 1 (best 0.71) |
| 6OXP | HIV-1 protease NL4-3 wt in complex with UMASS3 | x-ray diffraction | B, A | SO4, K2A | 1 (best 0.71) |
| 6OXQ | HIV-1 Protease NL4-3 WT in Complex with UMass8 | x-ray diffraction | B, A | SO4, F53 | 1 (best 0.72) |
| 6OXQ | HIV-1 protease NL4-3 wt in complex with UMASS8 | x-ray diffraction | B, A | SO4, F53 | 1 (best 0.72) |
| 6OXR | HIV-1 Protease NL4-3 WT in Complex with LR-82 | x-ray diffraction | B, A | NJA | 1 (best 0.71) |
| 6OXR | HIV-1 protease NL4-3 wt in complex with lr-82 | x-ray diffraction | B, A | NJA | 1 (best 0.71) |
| 6OXS | HIV-1 Protease NL4-3 WT in Complex with LR-76 | x-ray diffraction | B, A | NJ4 | 1 (best 0.71) |
| 6OXS | HIV-1 protease NL4-3 wt in complex with lr-76 | x-ray diffraction | B, A | NJ4 | 1 (best 0.71) |
| 6OXT | HIV-1 Protease NL4-3 WT in Complex with LR-84 | x-ray diffraction | B, A | SO4, NEJ | 1 (best 0.72) |
| 6OXT | HIV-1 protease NL4-3 wt in complex with lr-84 | x-ray diffraction | B, A | SO4, NEJ | 1 (best 0.72) |
| 6OXU | HIV-1 Protease NL4-3 WT in Complex with LR-99 | x-ray diffraction | B, A | SO4, NE7 | 1 (best 0.70) |
| 6OXU | HIV-1 protease NL4-3 wt in complex with lr-99 | x-ray diffraction | B, A | SO4, NE7 | 1 (best 0.70) |
| 6OXV | HIV-1 Protease NL4-3 WT in Complex with LR-85 | x-ray diffraction | B, A | NF4 | 1 (best 0.70) |
| 6OXV | HIV-1 protease NL4-3 wt in complex with lr-85 | x-ray diffraction | B, A | NF4 | 1 (best 0.70) |
| 6OXW | HIV-1 Protease NL4-3 WT in Complex with LR-100 | x-ray diffraction | B, A | NFJ | 1 (best 0.71) |
| 6OXW | HIV-1 protease NL4-3 wt in complex with lr-100 | x-ray diffraction | B, A | NFJ | 1 (best 0.71) |
| 6OXX | HIV-1 Protease NL4-3 WT in Complex with LR2-18 | x-ray diffraction | B, A | NF7 | 1 (best 0.72) |
| 6OXX | HIV-1 protease NL4-3 wt in complex with LR2-18 | x-ray diffraction | B, A | NF7 | 1 (best 0.72) |
| 6OXY | HIV-1 Protease NL4-3 WT in Complex with LR2-19 | x-ray diffraction | B, A | SO4, NG4 | 1 (best 0.72) |
| 6OXY | HIV-1 protease NL4-3 wt in complex with LR2-19 | x-ray diffraction | B, A | SO4, NG4 | 1 (best 0.72) |
| 6OXZ | HIV-1 Protease NL4-3 WT in Complex with LR2-20 | x-ray diffraction | B, A | SO4, NJG | 1 (best 0.72) |
| 6OXZ | HIV-1 protease NL4-3 wt in complex with LR2-20 | x-ray diffraction | B, A | SO4, NJG | 1 (best 0.72) |
| 6OY0 | HIV-1 Protease NL4-3 WT in Complex with LR2-21 | x-ray diffraction | B, A | SO4, NJ7 | 1 (best 0.71) |
| 6OY0 | HIV-1 protease NL4-3 wt in complex with LR2-21 | x-ray diffraction | B, A | SO4, NJ7 | 1 (best 0.71) |
| 6OY1 | HIV-1 Protease NL4-3 WT in Complex with LR2-26 | x-ray diffraction | B, A | SO4, NJ1 | 1 (best 0.72) |
| 6OY1 | HIV-1 protease NL4-3 wt in complex with LR2-26 | x-ray diffraction | B, A | SO4, NJ1 | 1 (best 0.72) |
| 6OY2 | HIV-1 Protease NL4-3 WT in Complex with LR2-25 | x-ray diffraction | B, A | NJJ, SO4 | 1 (best 0.72) |
| 6OY2 | HIV-1 protease NL4-3 wt in complex with LR2-25 | x-ray diffraction | B, A | NJJ, SO4 | 1 (best 0.72) |
| 6PJB | HIV-1 Protease NL4-3 WT in Complex with Lopinavir | x-ray diffraction | B, A | SO4, AB1 | 1 (best 0.71) |
| 6PJB | HIV-1 protease NL4-3 wt in complex with lopinavir | x-ray diffraction | B, A | SO4, AB1 | 1 (best 0.71) |
| 6PJC | HIV-1 Protease NL4-3 WT in Complex with LR4-41 | x-ray diffraction | B, A, D, C | SO4, OR1 | 4 (best 0.71) |
| 6PJC | HIV-1 protease NL4-3 wt in complex with LR4-41 | x-ray diffraction | B, A, D, C | SO4, OR1 | 4 (best 0.71) |
| 6PJD | HIV-1 Protease NL4-3 WT in Complex with LR2-32 | x-ray diffraction | B, A | SO4, OQY | 1 (best 0.72) |
| 6PJD | HIV-1 protease NL4-3 wt in complex with LR2-32 | x-ray diffraction | B, A | SO4, OQY | 1 (best 0.72) |
| 6PJE | HIV-1 Protease NL4-3 WT in Complex with LR2-43 | x-ray diffraction | B, A | OPJ, SO4 | 1 (best 0.71) |
| 6PJE | HIV-1 protease NL4-3 wt in complex with LR2-43 | x-ray diffraction | B, A | OPJ, SO4 | 1 (best 0.71) |
| 6PJF | HIV-1 Protease NL4-3 WT in Complex with LR2-44 | x-ray diffraction | B, A | SO4, OP7 | 1 (best 0.73) |
| 6PJF | HIV-1 protease NL4-3 wt in complex with LR2-44 | x-ray diffraction | B, A | SO4, OP7 | 1 (best 0.73) |
| 6PJG | HIV-1 Protease NL4-3 WT in Complex with LR3-97 | x-ray diffraction | B, A | ORV | 1 (best 0.71) |
| 6PJG | HIV-1 protease NL4-3 wt in complex with LR3-97 | x-ray diffraction | B, A | ORV | 1 (best 0.71) |
| 6PJH | HIV-1 Protease NL4-3 WT in Complex with LR3-28 | x-ray diffraction | B, A | OQG, SO4 | 1 (best 0.71) |
| 6PJH | HIV-1 protease NL4-3 wt in complex with LR3-28 | x-ray diffraction | B, A | OQG, SO4 | 1 (best 0.71) |
| 6PJI | HIV-1 Protease NL4-3 WT in Complex with LR3-43 | x-ray diffraction | B, A | OO4, SO4 | 1 (best 0.71) |
| 6PJI | HIV-1 protease NL4-3 wt in complex with LR3-43 | x-ray diffraction | B, A | OO4, SO4 | 1 (best 0.71) |
| 6PJK | HIV-1 Protease NL4-3 WT in Complex with LR3-29 | x-ray diffraction | B, A | OQD, SO4 | 1 (best 0.71) |
| 6PJK | HIV-1 protease NL4-3 wt in complex with LR3-29 | x-ray diffraction | B, A | OQD, SO4 | 1 (best 0.71) |
| 6PJL | HIV-1 Protease NL4-3 WT in Complex with LR3-95 | x-ray diffraction | B, A | SO4, OQA | 1 (best 0.73) |
| 6PJL | HIV-1 protease NL4-3 wt in complex with LR3-95 | x-ray diffraction | B, A | SO4, OQA | 1 (best 0.73) |
| 6PJM | HIV-1 Protease NL4-3 WT in Complex with LR2-35 | x-ray diffraction | A, B | SO4, OQV | 1 (best 0.71) |
| 6PJM | HIV-1 protease NL4-3 wt in complex with LR2-35 | x-ray diffraction | A, B | SO4, OQV | 1 (best 0.71) |
48 records more on the page itself.
Ligands
- SO4 · Sulfate ion · in 92 records
- 017 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate · in 4 records
- 065 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(2s,3r)-3-hydroxy-4-(N-isobutylbenzo[d][1,3]dioxole-5-sulfonamido)-1-phenylbutan-2-ylcarbamate · in 2 records
- A60 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-ethylbutyl)amino}-1-benzyl-2-hydroxypropyl]carbamate · in 2 records
- A61 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(1S,2R)-3-[(1,3-benzothiazol-6-ylsulfonyl)(2-ethylbutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate · in 2 records
- AB1 · N-{1-benzyl-4-[2-(2,6-dimethyl-phenoxy)-acetylamino]-3-hydroxy-5-phenyl-pentyl}-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide · in 2 records
- DJR · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-{isobutyl[(4-methoxyphenyl) sulfonyl]amino}propyl]carbamate · in 2 records
- F53 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl {(1S,2R)-1-benzyl-3-[(2-ethylbutyl){[4-(hydroxymethyl) phenyl]sulfonyl}amino]-2-hydroxypropyl}carbamate · in 2 records
- K13 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl][(2S)-2-methylbutyl]amino}-1-benzyl-2-hydroxypropyl]carbamate · in 2 records
- K14 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl][(2S)-2-methylbutyl]amino}propyl]carbamate · in 2 records
- K19 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-1-benzyl-2-hydroxypropyl]carbamate · in 2 records
- K20 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-{(1,3-benzodioxol-5-ylsulfonyl)[(2S)-2-methylbutyl]amino}-1-benzyl-2-hydroxypropyl]carbamate · in 2 records
- K2A · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-({[4-(hydroxymethyl) phenyl]sulfonyl}[(2s)-2-methylbutyl]amino) propyl]carbamate · in 2 records
- K2D · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-1-benzyl-3-{(2-ethylbutyl)[(4-methoxyphenyl) sulfonyl]amino}-2-hydroxypropyl]carbamate · in 2 records
- K2E · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-ethylbutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate · in 2 records
- KGQ · Diethyl ({4-[(2S,3R)-2-({[(3r,3as,6ar)-hexahydrofuro[2, 3-b]furan-3-yloxy]carbonyl}amino)-3-hydroxy-4-{isobutyl[(4-methoxyphenyl) sulfonyl]amino}butyl]phenoxy}methyl)phosphonate · in 2 records
- NE7 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-3-hydroxy-4-{({4-[(1R)-1-hydroxyethyl]phenyl}sulfonyl) [(2S)-2-methylbutyl]amino}-1-phenylbutan-2-yl]carbamate · in 2 records
- NEJ · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-3-hydroxy-4-{({4-[(1S)-1-hydroxyethyl]phenyl}sulfonyl) [(2S)-2-methylbutyl]amino}-1-phenylbutan-2-yl]carbamate · in 2 records
- NF4 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[(2-ethylbutyl)({4-[(1S)-1-hydroxyethyl]phenyl}sulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate · in 2 records
- NF7 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[({4-[(1R)-1,2-dihydroxyethyl]phenyl}sulfonyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate · in 2 records
- NFJ · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[(2-ethylbutyl)({4-[(1R)-1-hydroxyethyl]phenyl}sulfonyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate · in 2 records
- NG4 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[({4-[(1S)-1,2-dihydroxyethyl]phenyl}sulfonyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate · in 2 records
- NJ1 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[({4-[(1R)-1,2-dihydroxyethyl]phenyl}sulfonyl)(2-ethylbutyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate · in 2 records
- NJ4 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-3-hydroxy-4-[({4-[(1R)-1-hydroxyethyl]phenyl}sulfonyl) (2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate · in 2 records
- NJ7 · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{({4-[(1S)-1,2-dihydroxyethyl]phenyl}sulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate · in 2 records
- NJA · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-3-hydroxy-4-[({4-[(1S)-1-hydroxyethyl]phenyl}sulfonyl) (2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate · in 2 records
- NJG · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{({4-[(1R)-1,2-dihydroxyethyl]phenyl}sulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate · in 2 records
- NJJ · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[({4-[(1S)-1,2-dihydroxyethyl]phenyl}sulfonyl)(2-ethylbutyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate · in 2 records
- NJM · (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-3-hydroxy-4-[{[4-(hydroxymethyl)phenyl]sulfonyl}(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate · in 2 records
- OO4 · Methyl [(1S)-1-cyclopropyl-2-({(2S,3S,5S)-5-[({[(3R, 3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl]oxy}carbonyl) amino]-3-hydroxy-1,6-diphenylhexan-2-yl}amino)-2-oxoethyl]carbamate · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.